“Scleroderma Research Efforts and the Importance of Patient Participation"
Vivien Hsu, MD
Patient Educational Forum, New Brunswick NJ
October 16, 2016
The information presented on this site is intended for educational purposes only. Neither the featured speakers, nor the Scleroderma Foundation, nor Starlight Productions ( the producers of these videos) suggest, recommend or endorse any specific treatment for any individual. Patients are advised consult their own health care providers for treatment options.
About Dr. Hsu:
Dr. Vivien Hsu is an Associate Professor of Medicine at Robert Wood Johnson University Hospital. She performed her residency in internal medicine at the University of Medicine and Dentistry of Newark, NJ. Dr. Hsu continued her studies and performed her fellowship training in rheumatology at Robert Wood Johnson. Dr. Hsu is the Director of the UMDNJ Scleroderma Research Program. This research actively involves multiple clinical trials of novel treatments and antifibrotic agents for systemic sclerosis. The research aims to find better treatment options for pulmonary fibrosis, pulmonary hypertension, Raynaud's, digital ulcers, myopathy, and other complications seen with this devastating disease.